Pharmaceutics (Dec 2022)

Glycyrrhizin-Based Hydrogels Accelerate Wound Healing of Normoglycemic and Diabetic Mouse Skin

  • Maarten A. Mees,
  • Fleur Boone,
  • Thomas Bouwen,
  • Frederik Vanaerschot,
  • Charlotte Titeca,
  • Hanna-Kaisa Vikkula,
  • Leen Catrysse,
  • Anja Vananroye,
  • Erin Koos,
  • Stelios Alexandris,
  • Sabine Rosenfeldt,
  • Samuel Eyley,
  • Joachim Koetz,
  • Geert van Loo,
  • Wim Thielemans,
  • Esther Hoste

DOI
https://doi.org/10.3390/pharmaceutics15010027
Journal volume & issue
Vol. 15, no. 1
p. 27

Abstract

Read online

Efficient wound repair is crucial for mammalian survival. Healing of skin wounds is severely hampered in diabetic patients, resulting in chronic non-healing wounds that are difficult to treat. High-mobility group box 1 (HMGB1) is an important signaling molecule that is released during wounding, thereby delaying regenerative responses in the skin. Here, we show that dissolving glycyrrhizin, a potent HMGB1 inhibitor, in water results in the formation of a hydrogel with remarkable rheological properties. We demonstrate that these glycyrrhizin-based hydrogels accelerate cutaneous wound closure in normoglycemic and diabetic mice by influencing keratinocyte migration. To facilitate topical application of glycyrrhizin hydrogels on cutaneous wounds, several concentrations of glycyrrhizinic acid in water were tested for their rheological, structural, and biological properties. By varying the concentration of glycyrrhizin, these hydrogel properties can be readily tuned, enabling customized wound care.

Keywords